A Phase I, Open Label, Dual Centre Study To Assess The Safety And Tolerability Of AZD2281 In Combination With Bevacizumab (Avastin) In Patients With Advanced Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2015
At a glance
- Drugs Bevacizumab; Olaparib
- Indications Solid tumours
- Focus Adverse reactions
- 09 Dec 2010 Actual end date changed from May 2009 to Nov 2009 as reported by ClinicalTrials.gov.
- 28 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.